Abstract
Introduction

Liver fibrosis or cirrhosis is a common result of chronic liver disease such as that caused by excessive alcohol consumption or hepatitis virus infection. A main feature of liver fibrosis is overt deposition of scar tissue due to an increased expression/synthesis or impaired degradation of extracellular matrix (ECM) components such as collagen types I and III or fibronectin (FN), the latter of which is among first such proteins to be deposited in the space of Disse and around the central veins in experimental cirrhosis
. [3, 4] . In their activated state, HSC are highly proliferative, chemotactic and pro-fibrogenic, the latter of which is due to the action transforming growth factor ␤1 (TGF-␤1) which stimulates collagen production and is highly overexpressed in many fibrotic tissues [1] [2] [3] [4] . Recently, connective tissue growth factor (CCN2, also known as CTGF), a mosaic matricellular protein containing four evolutionarily conserved structural modules, has emerged as an important player in the fibrotic response because it acts downstream of TGF-␤ and interacts co-operatively with TGF-␤ to enhance fibrotic pathways [5, 6] , although the underlying mechanisms are complex and likely highly dependent on the cell type and environmental context [5, 7] . Nonetheless [5, [8] [9] [10] [11] [12] [13] .
Hepatic stellate cells (HSC) are a principal source of hepatic ECM, especially during fibrosing liver injury when they become transcriptionally activated and highly responsive to growth factors and chemokines that are released by injured hepatocytes or infiltrating macrophages
The exact mechanisms by which CCN2 drives HSC activation and liver fibrosis are unclear even though it is well documented that CCN2 plays important roles in cell proliferation, cell survival and apoptosis, cell adhesion and migration [7, [14] [15] [16] [17] . We and others have previously reported that integrins ␣v␤3 and ␣5␤1 are CCN2 receptors on, respectively, rat HSC or rat pancreatic stellate cells [15, [17] [18] [19] 
and 5Ј-CT T T TC ACG GT T GGC CT T AG-3Ј (antisense) (130 bp); CCN2: 5Ј-CCA GGA AGT AAG GGA CAC GA-3Ј (sense) and 5Ј-GGT TCT CAC T T T GGT GGG AT-3Ј (antisense) (148 bp); integrin ␣5: 5Ј-CT T AGA ATC CGA GAC TGG GC-3Ј (sense) and 5Ј-TCA GGA CAA ATC CCA AAC AA-3Ј (antisense) (126 bp); integrin ␣v: 5Ј-TCC CAG GAC TGT ATT GCT GA-3Ј (sense) and 5Ј-CAG TGT GGG CGA AGT AAA TG-3Ј (antisense) (119 bp); integrin ␤1: 5Ј-TCA CAA ATA CTG TAA GCT GTC C-3Ј (sense) and 5Ј-AGC ACT GTC AAA ATG AAA AGG C-3Ј (antisense) (200 bp); integrin ␤3: 5Ј-ACT GTG CCT GCC AGG CCT TT-3Ј (sense) and 5Ј-TCC TTG GGG CTG CAC TCT TC-3Ј (antisense) (169 bp
Cell adhesion assay
Cell adhesion assays were performed as described [15, 17] . [15, 17, 19, [23] [24] [25] [26] [27] .
Co-operative interaction between CCN2 and FN in promoting mHSC adhesion
CCN21-4 or CCN24 (200 ng/ml) promoted mHSC adhesion to FN by 2.2-and 1.5-fold, respectively, but their effects were decreased 62% or 50%, respectively, by anti-integrin ␣5␤1 antibody (10 g/ml) (Fig. 7). Similarly, FN (200 ng/ml) promoted mHSC adhesion to CCN21-4 by 1.9-fold, but pre-treatment of the cells with heparinase I (2 units/ml) decreased FN-enhanced cell adhesion by 53%, and prior occupancy of heparin-binding site by pre-incubation with
Engagement of cell surface integrins and HSPG by CCN2 likely represents a major mechanism for modulating the responses of the target cell to a diverse variety of molecular stimuli and environmental cues.
We have previously shown that adhesion of primary rat HSC to CCN2 employs an integrin ␣v␤3 binding site located in residues 247-239 [15] and that adhesion of the rat HSC-T6 cell line to CCN2 involves an integrin ␣6␤1 binding site in residues 199-243 [28] . In other studies we showed that integrin ␣5␤1 supported CCN2-mediated adhesion of primary rat pancreatic stellate cells [17, 18] . In view of the emerging importance of mouse models in probing CCN2 action in the liver in vivo [29, 30] [17] . Moreover, heparin-binding domains in CCN2 have been localized to stretches of highly basic residues in the C-terminal portion of the CCN2 molecule, including residues 247-260 and residues 274-286 [31] .
Because blocking antibodies to the mouse form of integrin ␣v␤3 are not available, we cannot exclude the possibility that integrin ␣v␤3 also plays a role in CCN2-induced adhesion of mHSC, as we have shown previously for rat HSC [15] . Indeed incubation of day 3 mHSC with echistatin, a snake venom disintegrin with high specificity for integrin ␤1 and ␤3, was somewhat more effective than anti-integrin ␣5␤1, anti-integrin ␤1 or anti-integrin In this study we showed that CCN2 expression increases as a function of culture-induced activation, consistent with previous data from other systems [10] . Although it has been documented that certain integrins are up-regulated in fibrotic liver disease or during HSC activation [32] [33] [34] [35] [36] [37] . We have further shown that the integrin ␣6 subunit, which also functions as a CCN2 receptor [28] , is also produced by primary mHSC on day 3 and day 7 but its expression appears to be independent of CCN2 stimulation (data not shown).
In this study we demonstrated that FN, which is also an integrin ␣5␤1 ligand in HSC [38] , interacts co-operatively with CCN2 to promote mHSC. Similar interactions have been reported for fibroblasts [24] , chondrocytes [25] and oval cells [19] , and FN has been shown to regulate the cellular response to CCN2 [39] . In the mHSC system, incubation with anti-integrin ␣5␤1 antibody or heparinase decreased CCN21-4-or CCN24-induced cell adhesion to FN, demonstrating that residues 247-349 were involved in this Fig. 6 CCN2 or FN 
